Hemopoietic stem cells: sources and applicationsDAE-SIK HONG; DEEG, H. J.Medical oncology and tumor pharmacotherapy. 1994, Vol 11, Num 2, pp 63-68, issn 0736-0118Conference Paper

The effect of water and acidity of the clay for ethylene polymerization over Cp₂ZrCl₂ supported on TMA-modified clay materialsDONG WOOK JEONG; DAE SIK HONG; HYUN YONG CHO et al.Journal of molecular catalysis. A, Chemical. 2003, Vol 206, Num 1-2, pp 205-211, issn 1381-1169, 7 p.Article

Poisoning effect of CO on ethylene polymerization with Ni(II)-diimine/MAODAE SIK HONG; DONG WOOK JEONG; HYUN YONG CHO et al.Polymer (Guildford). 2006, Vol 47, Num 1, pp 184-192, issn 0032-3861, 9 p.Article

Polymerization of methyl acrylate by a 2,6-bis(2-benzimidazyl)pyridine zirconium dichloride/MAO catalyst systemHYUN YONG CHO; NARESH HIRARAL TARTE; LIQIANG CUI et al.Macromolecular chemistry and physics (Print). 2006, Vol 207, Num 21, pp 1965-1971, issn 1022-1352, 7 p.Article

Current density dependence on performance degradation of direct methanol fuel cellsMIN KU JEON; KI RAK LEE; KWANG SEOK OH et al.Journal of power sources. 2006, Vol 158, Num 2, pp 1344-1347, issn 0378-7753, 4 p.Article

Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligandDAE-SIK HONG; BECKHAM, C; HUSS, R et al.Blood. 1995, Vol 86, Num 9, pp 3341-3352, issn 0006-4971Article

High-throughput synthesis of new Ni(II), Pd(II), and Co(II) catalysts and polymerization of norbornene utilizing the self-made parallel polymerization reactor systemHYUN YONG CHO; DAE SIK HONG; DONG WOOK JEONG et al.Macromolecular rapid communications. 2004, Vol 25, Num 1, pp 302-306, issn 1022-1336, 5 p.Article

Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesisYAMAGUCHI, M; MCSWEENEY, P. A; KIMBALL, L et al.Transplantation. 1999, Vol 68, Num 8, pp 1161-1171, issn 0041-1337Article

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancerHONG SUK SONG; YOUNG ROK DO; HEUNG MOON CHANG et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 5, pp 763-768, issn 0344-5704, 6 p.Article

A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancerHYUN JUNG KIM; NAM SU LEE; KYU TAEK LEE et al.Cancer chemotherapy and pharmacology. 2009, Vol 64, Num 2, pp 371-377, issn 0344-5704, 7 p.Article

Low-Dose Combinations of LBH589 and TRAIL Can Overcome TRAIL-resistance in Colon Cancer Cell LinesLEE, Sang-Cheol; CHEONG, Hee-Jeong; LEE, Namsu et al.Anticancer research. 2011, Vol 31, Num 10, pp 3385-3394, issn 0250-7005, 10 p.Article